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COnclusiOnS: Even though frequently focal, PBR is associated with a high incidence of 
recurrence, as well as a significant likelihood of late occlusion. Future investigations 
should address strategies to manage this condition. Serum Levels of High-Sensitive C-Reactive Protein 
Predict Restenosis After Stent Implantation in Patients 
With Unstable Angina 
1099- 188 Repeat Vascular Brachytherapy for Patients With In- 
Stent Restenosis Who Failed Radiation Therapy 
Hironori Ueda Yoshihiro Dohi, Yasuhiko Hayashi, Hitoshi Fujiwara, Yasuyuki Tomohiro, 
Yuji Muraoka, Mamoru Toyofuku, Takenori Okada, Shinji Mito, Ken Ishibashi, Michinori 
Imazu, Tsuchiya General Hospital, Hiroshima, Japan 
Robert Lew Ron Waksman. Andrew E. Ajani, Rebecca Torguson, Lowell F. Satler, -1 
William 0. Suddath, Nai-Chuen Yang, Ellen Pinnow, Barbara Pearson, Michael 
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Background: It has been suggested that a systemic marker such as C-reactive protein 
(CRP) is higher in patients wth unstable angina pectoris (UAP) than in those with stable 
angina petioris. Persistent elevation of CRP in patients with UAP is predictive of future 
myocardial ischemia and infarction. However, an association between the serum levels 
of CRP and restenosis after coronary stent implantation in patients with UAP has not 
been fully elucidated. Therefore, this study was designed to determine whether CRP cor- 
relates with in-stent restenosis in patients with UAP. Methods: The study group consisted 
of 59 patients with UAP (mean age 65.2 * 10.7 years, Braunwald type IB; n = 29, type IlB 
or 1118; n = 30) who underwent successful coronary artery stenting (total: 73 coronary 
lesions). Patients with known inflammatory disease, heart failure, acute myocardial inf- 
arction, and chronic renal failure were excluded. Serum samples obtained from patients 
were immediately analyzed for high sensitive (hs-) CRP concentration, which was deter- 
mined by the latex enhanced immunoassay. This assay has a detection limit of 2 pg /dl. 
A successful stenting was defined as a residual diameter stenosis of 50% of the lumen 
diameter as measured by quantitative computerized angiography at 6.month follow-up. 
Results: The hs-CRP serum levels were significantly higher in cases with restenosis (n = 
20) than I” those without restenosis (n = 53) (211.7 * 43.7 vs. 114.5 * 13.2 pg /dl. p = 
0.006). Preprocedural minimal lumen diameter was significantly lower in restenotic group 
than in group without restenosis (0.45 f 0.08 vs. 0.67 * 0.06 mm, p = 0.049). The inci- 
dence of restenosis was significantly higher in cases with hs-CRP levels > 165 pg /dl 
Background: Patients treated with intracoronary radiation therapy (IRT) for in-stent rest- 
enosis (ISR) have recurrences and require repeat revascularization to the previuosly irra- 
diated site. This study examined the safety and effectiveness of repeat radiation. 
Methods: 69 patients with ISR who had recurrence of stenosis at a previously irradiated 
segment and were assigned for revascularization were treated with repeat IRT utilizing 
gamma lrlg2 (n=26) with a prescribed dose of 15 Gy at 2 mm or beta (n=43) with either 
P3’ dose of 20 Gy at 1 .O mm beyond the balloon sudace or Sri’@’ with a dose of 16 or 
23Gy at 2 mm. The antiplatelet regimen was twelve months of clopidogrel. 
Results: The mean age was 64 + 11 years, 62.3% were males, 41.2% diabetics and 
58.2% pts had previous CABG. Sixty one ISR lesions were in native coronary arteries, 5 
in saphenous vein grafts and 2 in left internal mammary graft. The mean time interval 
between the two radiation treatments was 14.6 f 9.1 months and the mean number of 
previous interventions to the target lesion was 3.9 + 2.1. The radiation was delivered suc- 
cessfully in all patients with no procedural or hospital complications. At present 6 months 
clinical follow-up is available for 30 pts. (Table) No differences in events behveen beta or 
gamma were seen in patients that underwent repeat IRT to the same site. 
h-192 n=19 Srly90 and P32 n=ll Total n=30 
than in those with hs-CRP levels < 165 pg /dl(47.4% vs. 20.4%. p = 0.028). On multivari- Source 
ate analysis, the preprocedural CRP level (> 165 pg /dl) was the only independent pre- 0 0 0 
dictor of restenosis (relative risk [RR] = 2.22, p = 0.03). The clinical and demographic Death % 
characteristics of the population were similar for the two groups at baseline. Conclusion: 0 
Our results suggested that serum levels of hs-CRP predict restenosis after stent implan- 
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tation in patients with UAP. 
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1099 Brachytherapy and Management of In- 
Stent Restenosis Conclusions: Repeat radiation to the same site using either beta or gamma radiation for 
refractory ISR and failed IRT is safe and effective at 6 months. 
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1099- 189 Cutting Balloon Angioplssty Versus Rotational 
Atherectomy for Treatment of Diffuse In-Stent 
Restenosis: Multicenter Registry in Japan 
1099-l 87 Restenosis After Brachytherapy: Presentations and 
Outcomes 
Sunao Nakamura. Eita Saito, Takanori Miyauchi, Jin Yokoyama, Akihiko Kanazawa, 
Yasufumi Hayama, Koji Hozawa, Shotaro Nakamura, Hitoshi Nakamura, Kazutoshi 
Yamamoto, New Tokyo Hospital, Matsudo-shi, Japan, Kasori Hospital, Chiba-shi, Japan 
Steven L. Goldberg, Vassilis Spanos, Remo Albiero, Carlo Di Mario, Goran Stankovic, 
Nicola Corvaja, Damiana Milici, Massimo Ferraro, Antonio Colombo, University of 
Washington Medical Center, Seattle, WA, Centro Cuore Columbus, Milan, Italy 
Background: Brachytherapy (BT) has been shown to reduce restenosis after coronary 
intervention. Little is known however regarding recurrence after BT restenosis. Because 
restenosis after BT is frequently at the irradiated edge, and therefore often focal, it is pos- 
sible the recurrent restenosis rate is low. This study evaluated the clinical outcomes after 
treatment for post-brachytherapy restenosis (PBR). 
Methods: 79 consecutive lesions of PBR were found over the past 3 years. Patients with 
clinical stent thrombosis (occlusions presenting as myocardial infarctions) were 
excluded. BT and PBR films were analyzed side by side. Patients were followed for 
recurrent events (TVR) after the PBR was treated with coronary intervention (PCI). 
Findings: BT had been used for in-stent restenosis (62%) as well as de nova lesions. 
The PBR was focal (~10 mm) in 67% of lesions, attributable to geographic miss in 63% 
with edge restenosis in 66%. Seventy-two lesions with PBR were treated with an addi- 
tional PCI, with one failure. Two others were treated with bypass surgery. Clinical follow- 
up was achieved in 91%, (median of 6 months, range l-33). Total occlusions were seen 
in 16%, possibly due to late stent thrombosis. Incidence of recurrent restenosis, and for 
specific subsets, are shown in the Table. 
Recurrent Restenosis Rate 
Background: Diffuse in-stent restenosls (ISR) is still a challenging problem and optimal 
treatment has not been established. 
Method: To compare the efficacy and safety of cutting balloon angioprasty (CB) versus 
Rotational Atherectomy with adjunctive balloon angioplasty (Rota), for the treatment of 
ISR, we studied 662 patients (1046 lesions) with a first ISR. 432 patients (512 lesions) 
received Rota and 450 patients (534 lesions) received CB. Basic characteristics in both 
groups are similar. 
Results: See table for immediate and long-term clinical outcomes between CB and 
Rota. 
Conclusions: These data shows that Rotational Atherectomy with adjunctive balloon 
angioplasty seems to offer a better long-term clinical outcome than cutting balloon angio- 
plasty. Randomized trial is needed. 
Characteristic 
Overall 45% 
Focal PBR 49% 
Edge restenosis 47% 
Geographic miss 45% 
Total occlusion PBR 29% 
BT done for in-stent restenosis 44% 
Gamma radiation 50% 
Beta radiation 45% 
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In-hospital 
Procedural s”ccess (%) 98.7 99.1 NS 
MACE at 30 days (%) 0 0 
Lesion Length (mean: mm) 22.6 24.5 NS 
Reference diameter (mean: mm) 2.72 2.83 NS 
Post MLD (mean: mm) 2.20 2.73 p.zo.05 
p<o.o5 
pco.05 
pco.05 
p<o.o5 
Angiogaraphic follow-up at 6 months 
Follow-upMLD (mean: mm) 
Restenosis (%) 
TLR (%) 
Event free suwival (12 months) (%) 56.9 71.5 
CB ROta 
(Il=450) (n=432) 
1.55 
41.6 
32.6 
2.03 
27.6 
20.6 
P 
MACE: Major Adverse Cardiac Event (death / CABG I Ml: Myocardial Infarction) 
MLD: Minimum Lumen Diameter 
TLR: Target Lesion Revascularizatlon 
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In-stent restenosis remains a major problem after coronary stenting. The Cutting Bal- 
loonTM (CB) is a new device which has shown promise in the reduction of in-stent rest- 
enosis. We report here interim results of the REDUCE Ill study; a prospective, 
randomized, multi-center trial to investigate the safety and effectiveness of CB angio- 
plasty followed by stenting, compared to Plain Old Balloon Angioplasty (POBA) followed 
bv stentina, for the reduction of in&ant restenosis. Method: A total of 523 patients were _ 
randomized to either CB angioplasty or POBA, followed by stentlng. Patients underwent 
follow-uo anaioarams at 6 months. Pnmarv endooint was TLR at 6 month follow-uo. 
Results; Analysis for the initial 261 patient: has been completed (CB: 135 pts. POBA: 
146 pts). There were no differences in patient or lesion characteristics; coronary risk fac- 
tors, including diabetes mellitus (CB: 71/260, 27.3%; POBA: 671262, 33.2%); or in proce- 
dural success rates (CB 99.2% vs. POBA 96.4%). The preliminary analysis for the initial 
261 patients shows no significant difference as yet for TLR (CB: 14/135, 10%; POBA: 201 
146, 17%; p = 0.07); however, TLR tends to be higher for POBA than CB. Conclusion: 
CB angioplasty followed by stenting seems to decrease TLR. The final QCA data results 
will be presented at the next meeting. 
1099-191 Adventitial Response and Expansive Remodeling After 
Intravascular Brachytherapy in a Rabbit Model of 
Restenosis 
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Background: The incidence of late major adverse cardiac events after vascular brachy- 
therapy is higher than in controls. Because expansive remodeling has been shown to 
correlate with a poor clinical outcome after vascular interventions, we studied adventitial 
changes and arterial remodeling after intravascular irradiation in an animal model of rest- 
enosis. 
Methods: Twenty nonolipidemic rabbits underwent balloon Injury in both external iliac 
arteries. One artery was randomly assigned for subsequent irradiation with an 9OY 
sowce (15 Gy or 30 Gy at 0.5 mm in the vessel wall). After 4 weeks morphometnc mea- 
surements were performed and cell density, collagen amount, and the extent of alterial 
remodeling were determined. Staining for Ki67 identified proliferating cells: apoptotic 
cells were identified by in situ end-labeling of fragmented DNA, and indices were calcu- 
lated as positive cells/total cell count x100. 
Results: The neointlmal area decreased to 0.27*0.3mm2 after irradiaiion vs. 
0.5550.2mm2 in controls (p=O.O07), whereas the adventitia increased from 
0.62+0.3mm2 to 0.67+0.3mm2 (~~0.02). The expansive remodeling observed after irra- 
diation correlated directly with the adventitlal area (p<O.OOOl, r=0.63) and inversely with 
neointimal area (p=O.OOOl, rz0.57). Irradiation reduced the proliferative (0.95+2.6 vs. 
3.73t4.7, p=O.O26) and the apoptotic Index (0.006iO.02 vs. 0.107+0.2. p=O.O3) in the 
neointima, but not in the other arterial wall layers. There was no difference between 15 
and 30Gy in any of the parameters, although adventitial thickening was mole pro- 
nounced in the high-dose group 
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Conclusion: The occurrence of adventitial thickening and expanwe remodeling after 
intravascular irradiation might explain the increased incidence of late MACE after coro- 
nary brachytherapy. 
1099-l 92 A Risk Score for Prediction of Contrast Induced 
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Roxana Mehran, Eve D. Aymong, George Dangas, Andrea S. Abizaid, Alexandre A. 
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Background: Contrast induced nephropathy (GIN) IS a common cause of renal failure 
and correlates with higher in-hospital and late mortality after percutaneous coronary 
intervention (PCl).Obiective: To develoo a simole risk score that has broad apolicabilitv. . 
is easily calculated at presentation, and identifies pts with different responses to contrast 
exoosure. Methods: The Cardiovascular Research Foundation 1CRFI orosoective data- 
base was probed to identify 9726 consecutive pts undergoing PCI. Univariate predictors 
for CIN (defined as 25% rise in baseline creatinlne) were identified. The risk score was 
derived by selection of Independent prognostic variables using multivanate logistic 
regression. Assignment of value of 1 when a factor was present and 0 when it was 
absent, and summing the number of factors present to categorize patients into risk strata. 
Results: The eight risk score predictor variables were: Chronic renal failure ((X2.0 mg/ 
dl, or creatinine clearance <40cc/min), age > 70 yrs, diabetes mellitus, female gender, 
left ventricular ejection fraction < 40%, acute coronary syndrome presentation, contrast 
volume >15Occ, and IABP use. lncldence of CIN increased significantly as the risk score 
increased I” this cohort.(Figure). Conclusion: In pts undergoing PCI, the CRF risk score 
is a simple prognostic scheme that categorizes a pt’s risk of CIN and provides a basis for 
important modifications in the procedural related factors which are controlled by the oper- 
ator (ie: contrast volume). 
80x1 2 3 4 I 6 7rrs 
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With Gamma lntracoronarv Radiation: Six-Month 
Clinical and Angiographic-Outcomes 
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Background: lntracoronaly radiation therapy (IRT) has become the treatment strategy 
of choice for in-stent restenosis (ISR). However, its role I” totally occluded ISR lesions 
has been poorly characterized. The objective of this study was to evaluate the safety and 
long-term efficacy of gamma IRT in patients with totally occluded ISR lesions.Methods 
and Results: Six hundred and sixty nine consecutive patlents (pts) were selected from 
the WRIST (Washington Radiation for In-Stent Restenosis Trial) series of gamma IRT tri- 
als designed to assess the role of IRT for ISR. Of the total cohort, 66 (12.9%) pts had 
totally occluded (TO) ISR and had similar demographic and procedural characteristics to 
587 pts with non-total occlusion (NTO) ISR. Six-month clinical and angiographic out- 
comes were equivalent in both groups (Table). Eighty-two (95%) patients with TO ISR 
had successful recanalization with conventional percutaneous coronary intervention. 
TO ISR (N&2) NT0 ISR (N=587) P 
Late Loss, mm 0.6 * 0.9 0.4 * 0.7 0.12 
Angiographic Binary Restenosis, % 32 21 0 12 
Death, % 4 3 0.71 
Q-wave Myocardial Infarctton, % 3 1 0.36 
Target Lesion Revascularizatlon, % 2U 20 0.95 
Target Vessel Revascularization. % 24 28 0.41 
Late Thrombosis, % 6 4 0.13 
Major Adverse Cardiac Events, % 21 22 0.92 
Conclusions: Gamma IRT for ISR with total occlusion is feasible, safe, and associated 
with comparable outcomes as non-occlusive ISR. Totally occluded ISR lesions should 
become an important indication for gamma intracoronary radiation. 
